Acute and chronic traumatic encephalopathies: Pathogenesis and biomarkers

Steven T. Dekosky, Kaj Blennow, Milos D. Ikonomovic, Sam Gandy

Research output: Contribution to journalReview articlepeer-review

223 Scopus citations


Over the past decade, public awareness of the long-term pathological consequences of traumatic brain injury (TBI) has increased. Such awareness has been stimulated mainly by reports of progressive neurological dysfunction in athletes exposed to repetitive concussions in high-impact sports such as boxing and American football, and by the rising number of TBIs in war veterans who are now more likely to survive explosive blasts owing to improved treatment. Moreover, the entity of chronic traumatic encephalopathy (CTE) - which is marked by prominent neuropsychiatric features including dementia, parkinsonism, depression, agitation, psychosis, and aggression - has become increasingly recognized as a potential late outcome of repetitive TBI. Annually, about 1% of the population in developed countries experiences a clinically relevant TBI. The goal of this Review is to provide an overview of the latest understanding of CTE pathophysiology, and to delineate the key issues that are challenging clinical and research communities, such as accurate quantification of the risk of CTE, and development of reliable biomarkers for single-incident TBI and CTE.

Original languageEnglish
Pages (from-to)192-200
Number of pages9
JournalNature Reviews Neurology
Issue number4
StatePublished - Apr 2013


Dive into the research topics of 'Acute and chronic traumatic encephalopathies: Pathogenesis and biomarkers'. Together they form a unique fingerprint.

Cite this